The use of drug information sources by physicians: Development of a data-generating methodology

Haaijer‐Ruskamp, Flora; Reuyl, Jan C.; Versluis, A.

doi:10.1016/0277-9536(95)00152-2

Cited by 10 publications

(5 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Moreover, the fact that fellow winemakers are seen as a frequent source and disseminator of information is in no way unique in the broader context of practitioners. Medical practitioners also heavily rely on their medical colleagues for information and advice [12][13][14][15][16]. Asking colleagues is often the quickest way for busy practitioners to acquire relevant information, and also provides a sense of reassurance or direction in instances of uncertainty, apart from allowing a practitioner immediate access to the context-specific knowledge of others.…”

Section: Discussionmentioning

confidence: 99%

Use of scientific research by South African winemakers

Boshoff¹

2014

JCOM

View full text Add to dashboard Cite

The study investigated the extent to which transmission and cognition, the first two stages in the research use process, are accomplished for winemakers. “Transmission-cognition” was operationalized as the frequency of engagement with information sources considered to be carriers of scientific research. The study also investigated the prominence of four types of research use among winemakers (conceptual, symbolic, instrumental and persuasive) together with their inter-relationship. Conceptual use of scientific information was reported by 90% of winemakers and is a precursor to the other types of research use. Findings are discussed with reference to knowledge creep and the dissemination of scientific research through central winemakers acting as nodes in social networks.

show abstract

Section: Discussionmentioning

confidence: 99%

Use of scientific research by South African winemakers

Boshoff¹

2014

JCOM

View full text Add to dashboard Cite

show abstract

“…The firm-sponsored tours provide a platform for doctor interaction that affects intentions to adopt, also leading to WOM communication. Social influence has been operationalized by information coded in WOM communication, influencing medical decisions in hospitals (Boerkamp et al , 1996; Paraponaris et al , 2004; Wu et al , 2011). WOM communication is considered to be independent of commercial, direct marketing influences, in relation to sharing information between consumers about a product or service (Litvin et al , 2008).…”

Section: Literature Reviewmentioning

confidence: 99%

Communication drivers for drug adoption in an uncertain world

Goswami¹,

Boon‐itt

Jain

et al. 2016

IJPHM

View full text Add to dashboard Cite

Purpose The quality and reliability of medical communication for branded drug adoption is extremely critical, not only for safeguarding patient interests but also for ensuring successful investments by multinational pharmaceutical firms. This paper predicts doctors’ prescribing intentions based on communication relationship among factors for late entrant branded drugs, compared with pioneering brand choice, for treating chronic diseases such as hypertension. Design/methodology/approach The constructs were validated with structural equation model for a sample set of 151 doctors from private hospitals in the National Capital Region of India. Findings This research reveals communication drivers and draws on theory to suggest that the doctor’s behavioural prescription intentions, subject to social influence from their colleagues, leads to lower adoption responses. Research limitations/implications Given that limitations on sample size are often unavoidable, this study reveals that, due to the availability of substituting brands, alternate therapeutic routes and lack of availability of a practical guide for prescription, a communication model needs to be developed and validated. Practical implications Furthermore, managers of pharmaceutical firms should differentiate between the effects of direct and indirect communication–integration efforts for minimizing uncertainty in drug adoption in the context of the fragmented and unpredictable Indian market. Originality/value A late entrant may lose its dominant market share to alternate brands from other suppliers due to communication gaps in an unstructured market, leading to low adoption intentions. The study provides business theorists, drug marketers and health-care professionals with unique insights into specific communication drivers of prescribing decisions, aimed at ensuring reliable and appropriate drug adoption in Indian markets.

show abstract

“…These non-perceived, but nonetheless real needs, which are either poorly or not at all satisfied, are probably more numerous than the perceived needs [22][23][24]. This has been documented using two approaches: (a) interviews of physicians on markers of knowledge, reactions to fictitious cases, and the measurement of the gap between practice and available evidence [22][23][24][25][26][27]; and (b) systems analysis for errors in prescribing [28,29].…”

Section: Non-perceived Needsmentioning

confidence: 99%

How should therapeutic information be transferred to users?

Boissel¹,

Haugh²,

Fardeheb³

et al. 2003

Fundamemntal Clinical Pharma

View full text Add to dashboard Cite

Without an efficient solution to the problems that prevent prescribers and consumers having easy access to published and unpublished evidence, Evidence-Based Medicine will never become a reality. Among the problems, dissemination of the summarized evidence is a major one. It involves representing the summarized evidence in a format that corresponds to the users' needs and knowledge, interpreting it within the context of other related evidence, putting it in perspective, and then delivering it physically to the users at the appropriate time. The current formats, vehicles and representation models, e.g. those for guidelines or textbooks, do not seem efficient enough to fill in the gap of knowledge. We suggest that a new approach is possible by reducing the transferred information to its core and integrating it through appropriate representation models into the doctor's decision-making process.

show abstract

The use of drug information sources by physicians: Development of a data-generating methodology

Cited by 10 publications

References 6 publications

Use of scientific research by South African winemakers

Use of scientific research by South African winemakers

Communication drivers for drug adoption in an uncertain world

How should therapeutic information be transferred to users?

Contact Info

Product

Resources

About